ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P0246

   Investigation of Clostridium difficile positive and negative samples using an ultra-sensitive toxin detection assay and BIOFIRE FILMARRAY Gastrointestinal Panel

   Kerrie Davies, Leeds, United Kingdom

   Kerrie Davies , Virginie Viprey , Alice Banz , Duncan Ewin , William Spittal , Jonathan Vernon , Georgina Davis , Anthony Benson , Florence Frager , Philippe Cleuziat , Mark Miller , Mark H. Wilcox

   13 April 2019

   Session: More to learn about CDI: molecular diagnostics and epidemiology

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Diagnostic Bacteriology & General Microbiology

2. O0163

   Comparison of PCR-ribotypes and toxinotypes causing community versus hospital Clostridioides difficile infection

   Kerrie Davies, Leeds, United Kingdom

   Kerrie Davies , Virginie Viprey , Valerija Tkalec , Duncan Ewin , William Spittal , Jonathan Vernon , Warren Fawley , Anthony Benson , Georgina Davis , Maja Rupnik , Mark H. Wilcox

   13 April 2019

   Session: Controlling C. difficile in and out of the hospital

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Healthcare-associated & Nosocomial Infections, Infection Control

3. P0269

   Detection of Clostridium difficile infection across whole healthcare economies in Europe: results from COMBACTE-CDI

   Kerrie Davies, Leeds, United Kingdom

   Kerrie Davies , Virginie Viprey , Duncan Ewin , William Spittal , Jonathan Vernon , Warren Fawley , Anthony Benson , Georgina Davis , Mark H. Wilcox

   13 April 2019

   Session: CDI epidemiology and control

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Healthcare-associated & Nosocomial Infections, Infection Control

4. P0255

   Fidaxomicin, unlike conventional treatment options, reduces Clostridium difficile  environmental contamination during and at the end of therapy

   Kerrie Davies, Leeds, United Kingdom

   Kerrie Davies , Damian Mawer , Ann Sarah Walker , Claire Berry , Timothy Planche , Phil Stanley , Simon Goldenberg , Jonathan Sandoe , Mark H. Wilcox

   13 April 2019

   Session: More to learn about CDI: clinical management

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Healthcare-associated & Nosocomial Infections, Infection Control

5. P2267

   Do the results of membrane and well-based EIAs for the diagnosis of Clostridium difficile infection (CDI) correlate?

   Kerrie Davies, Leeds, United Kingdom

   K. Davies, I. Moura, K. Owen, C. Bates, H. Carr, M. Wilcox

   24 April 2018

   Session: What is happening in detecting and typing of Clostridium difficile?

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   Diagnostic Bacteriology & General Microbiology

6. P0367

   Predicting those at risk of recurrence; should we be monitoring Clostridium difficile infection patients with diagnostic assays?

   Kerrie Davies, Leeds, United Kingdom

   K. Davies, C. Berry, J. Heritage, M. Wilcox

   21 April 2018

   Session: Clostridium difficile - clinical news

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   Bacterial Infection & Disease

7. OS0221

   Multivariate analysis of factors affecting Clostridium difficile infection rates; the more you look, the more you find, but should you believe what you see?

   Kerrie Davies, Leeds, United Kingdom

   Kerrie Davies, Georgina Davis, Frédéric Barbut, Catherine Eckert, Nicola Petrosillo, Rafaella Pisapia, Elena Reigadas, Emilio Bouza Santiago, Fabian Berger, Mathias Herrmann, Mark H. Wilcox

   22 April 2017

   Session: Clostridium difficile infections: epidemiology and outcome

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Healthcare-associated & Nosocomial Infections, Infection Control

8. EP0174

   Adverse outcomes for missed cases of CDI; results from retrospective data collection on patients with samples received during the European, multi-centre, prospective bi-annual point prevalence study of Clostridium difficile infection in hospitalized patie

   Kerrie Davies, Leeds, United Kingdom

   K. Davies, G. Davis, F. Barbut, C. Eckert, P. Spigaglia, F. Barbanti, M. Herrmann, F. Berger, E. Bouza Santiago, E. Reigadas Ramírez, M. Wilcox0

   11 April 2016

   Session: Clostridium difficile: news on clinical epidemiology and novel approaches to therapy

   Relevance:

    

   100%

    

   

   Event: ECCMID 2016
   Amsterdam, The Netherlands
   ePoster presentation

   Healthcare-associated & Nosocomial Infections, Infection Control

9. O265

   Variability in testing policies and impact on Clostridium difficile infection rates; first report from the longitudinal European Clostridium difficile Infection Diagnosis Surveillance study (LuCID)

   Kerrie Davies, Leeds, United Kingdom

   Davies, Kerrie *; Davis, Georgina; Barbut, Frederic; Eckert, Catherine; Petrosillo, Nicola; Wilcox, Mark;

   28 April 2015

   Session: Dealing with Clostridium difficile

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Oral presentation

   Healthcare-associated & Nosocomial Infections, Infection Control

10. P0742

    Can a human gut model of Clostridium difficile infection (CDI) be used to explain GDH-positive/toxin-negative faecal samples seen in clinical practice?

    Kerrie Davies, Leeds, United Kingdom

    Davies, K.(1)*; Chilton, C.(1); Crowther, G.(1); Todhunter, S.(1); Heritage, J.(2); Wilcox, M.(1);

    11 May 2014

    Session: Diagnosis of Clostridium difficile and other gastrointestinal infections

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    Poster presentation

    Bacterial Infection & Disease